5,6-Dimethylimidazo<2,1-b>thiazol | 23576-87-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并噻唑类
• 英文名称: 5,6-Dimethylimidazo<2,1-b>thiazol
• 英文别名: 5,6-dimethyl-imidazo[2,1-b]thiazole；5,6-Dimethylimidazo[2,1-b][1,3]thiazole
• CAS: 23576-87-6
• 化学式: C₇H₈N₂S
• 分子量: 152.22
• InChiKey: BCHUIQRCIHMTQD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  45.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Kinase Inhibitors
  申请人：Wurster A. Julie

  公开号：US20070032478A1

  公开（公告）日：2007-02-08

  The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.

  本发明涉及有机分子，能够调节酪氨酸激酶信号传导，以调节、调控和/或抑制异常细胞增殖。
• PYRROLIDINES AND PIPERIDINES AS OREXIN RECEPTOR ANTAGONISTS
  申请人：Aissaoui Hamed

  公开号：US20100197733A1

  公开（公告）日：2010-08-05

  The invention relates to compounds of formula (I) wherein Y, A, N and R 1 are as described in the description, to salts, especially pharmaceutically acceptable salts, of such compounds and to the use of such compounds as medicaments, especially as orexin receptor antagonists.

  该发明涉及式（I）中的化合物，其中Y、A、N和R1如描述中所述，以及这些化合物的盐，特别是药用盐，以及将这些化合物用作药物，特别是作为促进睡眠的药物。
• HETEROCYCLIC AMIDES FOR USE AS PHARMACEUTICALS
  申请人：Arista Luca

  公开号：US20100261758A1

  公开（公告）日：2010-10-14

  Compounds of Formula (I) wherein R 1 is aryl, cyclohexyl or heterocyclyl, or (C 1-4 )alkyl substituted by aryl, cyclohexyl or heterocyclyl, R 2 is defined heterocyclyl, R 3 is alkyl, aryl, cyclohexyl or heterocyclyl, or (C 1-4 )alkyl substituted by aryl, cyclohexyl or heterocyclyl, R 4 is H or alkyl, or R 3 and R 4 together with the carbon atom to which they are attached are cycloalkyl fused with aryl, and their use as pharmaceuticals.

  化合物的公式（I），其中R1是芳基，环己基或杂环基，或被芳基，环己基或杂环基取代的（C1-4）烷基，R2是定义的杂环基，R3是烷基，芳基，环己基或杂环基，或被芳基，环己基或杂环基取代的（C1-4）烷基，R4是H或烷基，或R3和R4与它们所连接的碳原子一起是环状烷基与芳基融合，以及它们作为药物的用途。
• 2-CYCLOPROPYL-THIAZOLE DERIVATIVES
  申请人：Aissaoui Hamed

  公开号：US20100222328A1

  公开（公告）日：2010-09-02

  The invention relates to selected 2-cyclopropyl-thiazole derivatives of the formula (I) wherein B, Y and R1 are as described in the description; to salts and especially pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.

  该发明涉及公式（I）中所述的选择性2-环丙基噻唑衍生物，其中B、Y和R1如描述中所述；以及其盐，特别是药学上可接受的盐；以及将这些化合物用作药物，特别是促觉醒素受体拮抗剂的用途。
• [EN] PYRAZOLOPYRIDINE DERIVATIVES AND THEIR USE IN THERAPY<br/>[FR] DÉRIVÉS DE PYRAZOLOPYRIDINE ET LEUR UTILISATION EN THÉRAPIE
  申请人：HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT GMBH

  公开号：WO2016038045A1

  公开（公告）日：2016-03-17

  The present invention relates to pyrazolopyridine derivatives, which are useful as medicaments, pharmaceutical compositions comprising one or more of the pyrazolopyridine derivatives, and the use of one or more of the pyrazolopyridine derivatives in methods for treating and/or preventing a disease caused or mediated by a parasite of the family Trypanosomatidae.

  本发明涉及吡唑吡啶衍生物，其作为药物有用，包括一种或多种吡唑吡啶衍生物的制药组合物，以及使用一种或多种吡唑吡啶衍生物治疗和/或预防由Trypanosomatidae家族寄生虫引起或介导的疾病的方法。

表征谱图